Funder: Pfizer Inc.
Due Dates: July 9, 2024 (LOI/application) | July 4, 2025 (LOI/application) | June 15, 2026 (LOI/application)
Funding Amounts: Up to 1,200,000 JPY per project; project duration up to 2 years; includes direct and indirect costs (overhead capped at 28%).
Summary: Supports quality improvement projects in Japan to enhance migraine care through education, behavioral change, and systems development for early diagnosis and treatment.
Key Information: Only organizations (not individuals) are eligible; projects must focus on non-clinical quality improvement, not clinical research.